AustraliaA study involving 124,333 siblings conducted by researchers at the University of Hong Kong found no evidence linking maternal paracetamol use during pregnancy to autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD). This research challenges former U.S. President Donald Trump's 2025 claim that pregnant women should avoid paracetamol, which he referred to as 'Tylenol.' The Australian Medical Association and Australia’s Therapeutic Goods Administration dismissed Trump’s remarks, but Health Minister Mark Butler expressed concerns that such claims might deter pregnant women from using necessary medication. Researchers emphasized the importance of data-driven decisions over fear, noting that paracetamol is classified as a Category A drug in Australia and is considered safe for use during pregnancy. The study leveraged Hong Kong’s comprehensive electronic health records to analyze long-term patterns across a large cohort.
Bias read (Center): While the article discusses a politically sensitive issue—public health guidance versus political rhetoric—it presents balanced reporting. It includes criticism of Trump’s statement, acknowledges the concerns raised by health officials, and highlights the scientific consensus supporting paracetamol.
Why these scores (Factual 85 · Objective 70): Factuality is high as the article accurately reports the study's findings and contextualizes them against Trump's controversial remarks. Objectivity is lower due to the emotionally charged framing of Trump's comments as 'alarming' and the emphasis on replacing 'fear' with 'data', which subtly critic
